FDA Inspection
Graviti Pharmaceuticals Private LimitedGraviti Pharmaceuticals Private Limited – FDA Inspection, Aug 4, 2017
Record Details
This FDA Inspection record concerns Graviti Pharmaceuticals Private Limited, with an inspection on August 4, 2017, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · bd3ccd3e-29bf-406e-9764-95749485b4ad
Inspection Facts
- Inspection number
- 1020610
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Graviti Pharmaceuticals Private Limited
3| Date | Classification | Office | Project area |
|---|---|---|---|
| July 28, 2026 | Not classified | Office of Inspections and Investigations | Drug Quality Assurance |
| February 3, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 13, 2018 | Not classified | Office of Inspections and Investigations |
Other documents for Graviti Pharmaceuticals Private Limited
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.